Literature DB >> 2567028

A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety.

S R Bodnoff1, B Suranyi-Cadotte, R Quirion, M J Meaney.   

Abstract

We examined the anxiolytic effects of a variety of anti-depressant drugs, administered either acutely or chronically, in an animal model of anxiety involving novelty-suppressed feeding in food-deprived rats. Following a single injection of desipramine (10 mg/kg) amitriptyline (10 mg/kg), mianserin (10 mg/kg), fluoxetine (10 mg/kg), buspirone (4 mg/kg), gepirone (4 mg/kg) or nomifensine (10 mg/kg), there was no decrease in the latency to begin eating in the novel environment such as occurred with diazepam (2 mg/kg). In fact, an increased latency was observed for desipramine, amitriptyline, fluoxetine, and nomifensine. In contrast, chronic (21 days) treatment with each of the above-mentioned drugs, except nomifensine, significantly reduced the latency to begin eating relative to vehicle controls. These findings suggest that a variety of tricyclic and novel anti-depressant drugs acquire anxiolytic properties following chronic administration.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567028     DOI: 10.1007/BF00442264

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  INHIBITION OF UPTAKE OF TRITIATED-NORADRENALINE IN THE INTACT RAT BRAIN BY IMIPRAMINE AND STRUCTURALLY RELATED COMPOUNDS.

Authors:  J GLOWINSKI; J AXELROD
Journal:  Nature       Date:  1964-12-26       Impact factor: 49.962

Review 2.  Serotonin and anxiety revisited.

Authors:  R S Kahn; H M van Praag; S Wetzler; G M Asnis; G Barr
Journal:  Biol Psychiatry       Date:  1988-01-15       Impact factor: 13.382

Review 3.  Anxiety and drug therapy.

Authors:  D Kelly
Journal:  Proc R Soc Med       Date:  1973-03

4.  A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine.

Authors:  D T Wong; J S Horng; F P Bymaster; K L Hauser; B B Molloy
Journal:  Life Sci       Date:  1974-08-01       Impact factor: 5.037

5.  P-Chlorophenylalanine effects on a conditioned emotional response in rats.

Authors:  R J Hartmann; I Geller
Journal:  Life Sci I       Date:  1971-08-15

6.  Comparison of anti-conflict drug effects in three experimental animal models of anxiety.

Authors:  C D Kilts; R L Commissaris; R H Rech
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

7.  A simple and specific screen for benzodiazepine-like drugs.

Authors:  B P Poschel
Journal:  Psychopharmacologia       Date:  1971

8.  Effects of mianserin, a new antidepressant, on the in vitro and in vivo uptake of monoamines.

Authors:  I Goodlet; S E Mireylees; M F Sugrue
Journal:  Br J Pharmacol       Date:  1977-10       Impact factor: 8.739

9.  Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients.

Authors:  R J Kahn; D M McNair; R S Lipman; L Covi; K Rickels; R Downing; S Fisher; L M Frankenthaler
Journal:  Arch Gen Psychiatry       Date:  1986-01

10.  Nomifensine: A review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-07       Impact factor: 9.546

View more
  56 in total

1.  Duodenal calcium transporter mRNA expression in stressed male rats treated with diazepam, fluoxetine, reboxetine, or venlafaxine.

Authors:  Narattaphol Charoenphandhu; Jarinthorn Teerapornpuntakit; Sarawut Lapmanee; Nateetip Krishnamra; Jantarima Charoenphandhu
Journal:  Mol Cell Biochem       Date:  2012-07-06       Impact factor: 3.396

2.  The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression.

Authors:  Ramon O Tasan; Ngoc Khoi Nguyen; Stefan Weger; Simone B Sartori; Nicolas Singewald; Regine Heilbronn; Herbert Herzog; Günther Sperk
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

3.  Post-weaning chronic social isolation produces profound behavioral dysregulation with decreases in prefrontal cortex synaptic-associated protein expression in female rats.

Authors:  Gretchen Hermes; Nanxin Li; Catharine Duman; Ronald Duman
Journal:  Physiol Behav       Date:  2010-12-24

4.  A role for the mu opioid receptor in the antidepressant effects of buprenorphine.

Authors:  Shivon A Robinson; Rebecca L Erickson; Caroline A Browne; Irwin Lucki
Journal:  Behav Brain Res       Date:  2016-11-03       Impact factor: 3.332

5.  Cabergoline, a dopamine receptor agonist, has an antidepressant-like property and enhances brain-derived neurotrophic factor signaling.

Authors:  Shuichi Chiba; Tadahiro Numakawa; Midori Ninomiya; Hyung Shin Yoon; Hiroshi Kunugi
Journal:  Psychopharmacology (Berl)       Date:  2010-06-05       Impact factor: 4.530

6.  Attenuation of antipredator defensive behavior in rats following chronic treatment with imipramine.

Authors:  R J Blanchard; J K Shepherd; R J Rodgers; L Magee; D C Blanchard
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Ribosomal protein S6 kinase 1 signaling in prefrontal cortex controls depressive behavior.

Authors:  Jason M Dwyer; Jaime G Maldonado-Avilés; Ashley E Lepack; Ralph J DiLeone; Ronald S Duman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

8.  Ketamine administration during a critical period after forced ethanol abstinence inhibits the development of time-dependent affective disturbances.

Authors:  Oliver Vranjkovic; Garrett Winkler; Danny G Winder
Journal:  Neuropsychopharmacology       Date:  2018-05-24       Impact factor: 7.853

Review 9.  Mechanisms of pain from urinary tract infection.

Authors:  John M Rosen; David J Klumpp
Journal:  Int J Urol       Date:  2014-04       Impact factor: 3.369

Review 10.  The serotonergic system and anxiety.

Authors:  Joshua A Gordon; Rene Hen
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.